Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study

Clinical Presentation and Prognostic Features in Patients with Immunotherapy-Induced Vitiligo-like Depigmentation: A Monocentric Prospective Observational Study

Vitiligo-like depigmentation (VLD) is an immune-related adverse event (irAE) of checkpoint-inhibitor (CPI) treatment, which has previously been associated with a favourable outcome. The aim of this study was to explore clinical, biological and prognostic features of melanoma patients with VLD under...

Full description

Bibliographic Details
Main Authors: Nicola Hermann, Lara Valeska Maul, Milad Ameri, Stephan Traidl, Reihane Ziadlou, Karolina Papageorgiou, Isabel Kolm, Mitchell Levesque, Julia-Tatjana Maul, Marie-Charlotte Brüggen
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
melanoma
checkpoint inhibitors
immune-related toxicity
vitiligo
survival
LDH
Online Access:https://www.mdpi.com/2072-6694/14/19/4576

Internet

https://www.mdpi.com/2072-6694/14/19/4576

Similar Items